Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Acute Respiratory Distress Syndrome: A Prospective Observational Cohort Study

[1]  M. Nojomi,et al.  Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. , 2010, Journal of critical care.

[2]  E. Martin,et al.  Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation , 2009, European journal of anaesthesiology.

[3]  H. Fisher,et al.  Early drotrecogin alpha (activated) administration in severe sepsis is associated with lower mortality: a retrospective analysis of the Canadian ENHANCE cohort , 2009, Critical care.

[4]  J. Craig,et al.  Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: A systematic review and meta-analysis* , 2009, Critical care medicine.

[5]  A. Verbon,et al.  Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia , 2009, Intensive Care Medicine.

[6]  M. Kollef,et al.  Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. , 2009, Chest.

[7]  H. Fisher,et al.  Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis. , 2008, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[8]  Hsuan-Yu Chen,et al.  TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. , 2008, American journal of respiratory and critical care medicine.

[9]  E. Karapanagiotou,et al.  Soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) detection in cancer patients: a prognostic marker for lung metastases from solid malignancies. , 2008, Anticancer research.

[10]  E. Giamarellos‐Bourboulis,et al.  Evidence for the role of gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic ulcer disease. , 2007, World journal of gastroenterology.

[11]  L. Nace,et al.  Combined measurement of procalcitonin and soluble TREM-1 in the diagnosis of nosocomial sepsis , 2007, Scandinavian journal of infectious diseases.

[12]  I. Wakabayashi,et al.  [Alcohol abuse as a risk factor for ARDS]. , 2006, Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence.

[13]  E. Giamarellos‐Bourboulis,et al.  Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the pathogenesis of peptic ulcer disease , 2006, European journal of gastroenterology & hepatology.

[14]  H. Kondo,et al.  Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals. , 2006, Arthritis and rheumatism.

[15]  A. Isibasi,et al.  Expression of triggering receptor on myeloid cell 1 and histocompatibility complex molecules in sepsis and major abdominal surgery. , 2005, World journal of gastroenterology.

[16]  J. Korevaar,et al.  Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia , 2005, Intensive Care Medicine.

[17]  G. Rubenfeld,et al.  Causes and timing of death in patients with ARDS. , 2005, Chest.

[18]  S. Gibot Clinical review: Role of triggering receptor expressed on myeloid cells-1 during sepsis , 2005, Critical care.

[19]  M. Béné,et al.  Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis , 2005, Critical care medicine.

[20]  G. Bernard,et al.  Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury* , 2005, Critical care medicine.

[21]  P. Parsons,et al.  Significance of von Willebrand factor in septic and nonseptic patients with acute lung injury. , 2004, American journal of respiratory and critical care medicine.

[22]  Manoj-Kumar Gupta,et al.  Expression of TREM-1 mRNA in acute pancreatitis. , 2004, World journal of gastroenterology.

[23]  L. Fabbri,et al.  Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections , 2004, European Respiratory Journal.

[24]  S. Gibot,et al.  Soluble form of the triggering receptor expressed on myeloid cells-1 as a marker of microbial infection. , 2004, Clinical medicine & research.

[25]  P. Bollaert,et al.  Plasma Level of a Triggering Receptor Expressed on Myeloid Cells-1: Its Diagnostic Accuracy in Patients with Suspected Sepsis , 2004, Annals of Internal Medicine.

[26]  Mitchell M. Levy,et al.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock , 2004, Critical care medicine.

[27]  M. Béné,et al.  Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. , 2004, The New England journal of medicine.

[28]  M. Colonna,et al.  TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. , 2003, The Journal of infectious diseases.

[29]  J. Vincent,et al.  Epidemiology and outcome of acute respiratory failure in intensive care unit patients , 2003, Critical care medicine.

[30]  Mitchell M. Levy,et al.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference , 2003, Intensive Care Medicine.

[31]  M. Colonna,et al.  TREM-1 amplifies inflammation and is a crucial mediator of septic shock , 2001, Nature.

[32]  M. Colonna,et al.  Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes1 , 2000, The Journal of Immunology.

[33]  F. Brunkhorst,et al.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin. , 1999, Critical care medicine.

[34]  R. Strieter,et al.  Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[35]  M. Matthay,et al.  Identification of patients with acute lung injury. Predictors of mortality. , 1995, American journal of respiratory and critical care medicine.

[36]  R. Maunder,et al.  Clinical risks for development of the acute respiratory distress syndrome. , 1995, American journal of respiratory and critical care medicine.

[37]  M. Lamy,et al.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. , 1994, American journal of respiratory and critical care medicine.